Clinical Trial Update: First-In-Human Dose-Escalation Study of STP1002 in Patients With Advanced-Stage Solid Tumors [Phase 1]

View source ↗

Summary

This update reports the completion of a first-in-human dose-escalation Phase 1 trial of STP1002 in patients with solid tumors, assessing safety, tolerability an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• STP1002

Snippet

Sponsor: ST Pharm Co., Ltd. | Conditions: Advanced Solid Tumor | Phase 1 | Status: COMPLETED